Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice

Nine Knoers¹, Corinne Antignac², Carsten Bergmann^{3

4}, Karin Dahan^{5

6}, Sabrina Giglio^{7

8}, Laurence Heidet⁹, Beata S Lipska-Ziętkiewicz^{10

11}, Marina Noris¹², Giuseppe Remuzzi¹², Rosa Vargas-Poussou¹³, Franz Schaefer¹⁴

Affiliations

¹ Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands.
² Département de Génétique, Institut Imagine (Inserm U1163), Paris, France.
³ Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany.
⁴ Department of Medicine, Nephrology, University Hospital Freiburg, Freiburg, Germany.
⁵ Division of Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
⁶ Center of Human Genetics, Institut de Pathologie et de Génétique, Gosselies, Belgium.
⁷ Department of Medical Sciences and Public Health, Unit of Medical Genetics, University of Cagliari, Cagliari, Italy.
⁸ Department of Clinical and Experimental Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
⁹ Service de Néphrologie Pédiatrique, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
¹⁰ Centre for Rare Diseases, Medical University of Gdansk, Gdansk, Poland.
¹¹ Department of Biology and Medical Genetics, Clinical Genetics Unit, Medical University of Gdansk, Gdansk, Poland.
¹² Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Aldo & Cele Daccò Clinical Research Center for Rare Diseases, Bergamo, Italy.
¹³ Département de Génétique, Hôpital Européen Georges Pompidou, Paris, France.
¹⁴ Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.

PMID: 34264297
PMCID: PMC8788237
DOI: 10.1093/ndt/gfab218

Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice

Nine Knoers et al. Nephrol Dial Transplant. 2022.

. 2022 Jan 25;37(2):239-254.

doi: 10.1093/ndt/gfab218.

Authors

Affiliations

¹ Department of Genetics, University Medical Centre Groningen, Groningen, The Netherlands.
² Département de Génétique, Institut Imagine (Inserm U1163), Paris, France.
³ Medizinische Genetik Mainz, Limbach Genetics, Mainz, Germany.
⁴ Department of Medicine, Nephrology, University Hospital Freiburg, Freiburg, Germany.
⁵ Division of Nephrology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
⁶ Center of Human Genetics, Institut de Pathologie et de Génétique, Gosselies, Belgium.
⁷ Department of Medical Sciences and Public Health, Unit of Medical Genetics, University of Cagliari, Cagliari, Italy.
⁸ Department of Clinical and Experimental Biomedical Sciences "Mario Serio", University of Florence, Florence, Italy.
⁹ Service de Néphrologie Pédiatrique, Hôpital Universitaire Necker-Enfants Malades, Paris, France.
¹⁰ Centre for Rare Diseases, Medical University of Gdansk, Gdansk, Poland.
¹¹ Department of Biology and Medical Genetics, Clinical Genetics Unit, Medical University of Gdansk, Gdansk, Poland.
¹² Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Aldo & Cele Daccò Clinical Research Center for Rare Diseases, Bergamo, Italy.
¹³ Département de Génétique, Hôpital Européen Georges Pompidou, Paris, France.
¹⁴ Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, University of Heidelberg, Heidelberg, Germany.

PMID: 34264297
PMCID: PMC8788237
DOI: 10.1093/ndt/gfab218

Abstract

The overall diagnostic yield of massively parallel sequencing-based tests in patients with chronic kidney disease (CKD) is 30% for paediatric cases and 6-30% for adult cases. These figures should encourage nephrologists to frequently use genetic testing as a diagnostic means for their patients. However, in reality, several barriers appear to hinder the implementation of massively parallel sequencing-based diagnostics in routine clinical practice. In this article we aim to support the nephrologist to overcome these barriers. After a detailed discussion of the general items that are important to genetic testing in nephrology, namely genetic testing modalities and their indications, clinical information needed for high-quality interpretation of genetic tests, the clinical benefit of genetic testing and genetic counselling, we describe each of these items more specifically for the different groups of genetic kidney diseases and for CKD of unknown origin.

Keywords: chronic kidney disease; clinical benefit; genetic counselling; genetic testing; massively parallel sequencing; monogenic diseases.

PubMed Disclaimer

References

1. Bassanese G, Wlodkowski T, Servais A et al. The European Rare Kidney Disease Registry (ERKReg): objectives, design and initial results. Orphanet J Rare Dis 2021; 16: 251. - PMC - PubMed
1. Devuyst O, Knoers NV, Remuzzi G et al. Rare inherited kidney diseases: challenges, opportunities, and perspectives. Lancet 2014; 383: 1844–1859 - PMC - PubMed
1. Vivante A, Hildebrandt F. Exploring the genetic basis of early-onset chronic kidney disease. Nat Rev Nephrol 2016; 12: 133–146 - PMC - PubMed
1. Groopman EE, Marasa M, Cameron-Christie S et al. Diagnostic utility of exome sequencing for kidney disease. N Engl J Med 2019; 380: 142–151 - PMC - PubMed
1. Connaughton DM, Kennedy C, Shril S et al. Monogenic causes of chronic kidney disease in adults. Kidney Int 2019; 95: 914–928 - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice

Affiliations

Genetic testing in the diagnosis of chronic kidney disease: recommendations for clinical practice

Authors

Affiliations

Abstract

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical